45 results on '"Malaczynska-Rajpold, Katarzyna"'
Search Results
2. Beyond pulmonary vein isolation for persistent atrial fibrillation: sequential high-resolution mapping to guide ablation
- Author
-
Malaczynska-Rajpold, Katarzyna, Jarman, Julian, Shi, Rui, Wright, Piers, Wong, Tom, and Markides, Vias
- Published
- 2022
- Full Text
- View/download PDF
3. Acute and Long-Term Scar Characterization of Venous Ethanol Ablation in the Left Ventricular Summit
- Author
-
Fuentes Rojas, Stephanie C., Malahfji, Maan, Tavares, Liliana, Patel, Apoor, Schurmann, Paul A., Dave, Amish S., Tapias, Carlos, Rodríguez, Diego, Sáenz, Luis Carlos, Korolev, Sergey, Papiashvili, Giorgi, Peichl, Petr, Kautzner, Josef, Blaszyk, Krzysztof, Malaczynska-Rajpold, Katarzyna, Chen, Tiffany, Santangeli, Pasquale, Shah, Dipan J., and Valderrábano, Miguel
- Published
- 2023
- Full Text
- View/download PDF
4. Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
- Author
-
Linz, Dominik, primary, Andrade, Jason G, additional, Arbelo, Elena, additional, Boriani, Giuseppe, additional, Breithardt, Guenter, additional, Camm, A John, additional, Caso, Valeria, additional, Nielsen, Jens Cosedis, additional, De Melis, Mirko, additional, De Potter, Tom, additional, Dichtl, Wolfgang, additional, Diederichsen, Søren Zoega, additional, Dobrev, Dobromir, additional, Doll, Nicolas, additional, Duncker, David, additional, Dworatzek, Elke, additional, Eckardt, Lars, additional, Eisert, Christoph, additional, Fabritz, Larissa, additional, Farkowski, Michal, additional, Filgueiras-Rama, David, additional, Goette, Andreas, additional, Guasch, Eduard, additional, Hack, Guido, additional, Hatem, Stéphane, additional, Haeusler, Karl Georg, additional, Healey, Jeff S, additional, Heidbuechel, Hein, additional, Hijazi, Ziad, additional, Hofmeister, Lucas H, additional, Hove-Madsen, Leif, additional, Huebner, Thomas, additional, Kääb, Stefan, additional, Kotecha, Dipak, additional, Malaczynska-Rajpold, Katarzyna, additional, Merino, José Luis, additional, Metzner, Andreas, additional, Mont, Lluís, additional, Ng, Ghulam Andre, additional, Oeff, Michael, additional, Parwani, Abdul Shokor, additional, Puererfellner, Helmut, additional, Ravens, Ursula, additional, Rienstra, Michiel, additional, Sanders, Prashanthan, additional, Scherr, Daniel, additional, Schnabel, Renate, additional, Schotten, Ulrich, additional, Sohns, Christian, additional, Steinbeck, Gerhard, additional, Steven, Daniel, additional, Toennis, Tobias, additional, Tzeis, Stylianos, additional, van Gelder, Isabelle C, additional, van Leerdam, Roderick H, additional, Vernooy, Kevin, additional, Wadhwa, Manish, additional, Wakili, Reza, additional, Willems, Stephan, additional, Witt, Henning, additional, Zeemering, Stef, additional, and Kirchhof, Paulus, additional
- Published
- 2024
- Full Text
- View/download PDF
5. Longer and better lives for patients with atrial fibrillation:the 9th AFNET/EHRA consensus conference
- Author
-
Linz, Dominik, Andrade, Jason G., Arbelo, Elena, Boriani, Giuseppe, Breithardt, Guenter, Camm, A. John, Caso, Valeria, Nielsen, Jens Cosedis, De Melis, Mirko, De Potter, Tom, Dichtl, Wolfgang, Diederichsen, Søren Zoega, Dobrev, Dobromir, Doll, Nicolas, Duncker, David, Dworatzek, Elke, Eckardt, Lars, Eisert, Christoph, Fabritz, Larissa, Farkowski, Michal, Filgueiras-Rama, David, Goette, Andreas, Guasch, Eduard, Hack, Guido, Hatem, Stéphane, Haeusler, Karl Georg, Healey, Jeff S., Heidbuechel, Hein, Hijazi, Ziad, Hofmeister, Lucas H., Hove-Madsen, Leif, Huebner, Thomas, Kääb, Stefan, Kotecha, Dipak, Malaczynska-Rajpold, Katarzyna, Merino, José Luis, Metzner, Andreas, Mont, Lluís, Andre Ng, Ghulam, Oeff, Michael, Parwani, Abdul Shokor, Puererfellner, Helmut, Ravens, Ursula, Rienstra, Michiel, Sanders, Prashanthan, Scherr, Daniel, Schnabel, Renate, Schotten, Ulrich, Sohns, Christian, Steinbeck, Gerhard, Steven, Daniel, Toennis, Tobias, Tzeis, Stylianos, van Gelder, Isabelle C., van Leerdam, Roderick H., Vernooy, Kevin, Wadhwa, Manish, Wakili, Reza, Willems, Stephan, Witt, Henning, Zeemering, Stef, Kirchho, Paulus, Linz, Dominik, Andrade, Jason G., Arbelo, Elena, Boriani, Giuseppe, Breithardt, Guenter, Camm, A. John, Caso, Valeria, Nielsen, Jens Cosedis, De Melis, Mirko, De Potter, Tom, Dichtl, Wolfgang, Diederichsen, Søren Zoega, Dobrev, Dobromir, Doll, Nicolas, Duncker, David, Dworatzek, Elke, Eckardt, Lars, Eisert, Christoph, Fabritz, Larissa, Farkowski, Michal, Filgueiras-Rama, David, Goette, Andreas, Guasch, Eduard, Hack, Guido, Hatem, Stéphane, Haeusler, Karl Georg, Healey, Jeff S., Heidbuechel, Hein, Hijazi, Ziad, Hofmeister, Lucas H., Hove-Madsen, Leif, Huebner, Thomas, Kääb, Stefan, Kotecha, Dipak, Malaczynska-Rajpold, Katarzyna, Merino, José Luis, Metzner, Andreas, Mont, Lluís, Andre Ng, Ghulam, Oeff, Michael, Parwani, Abdul Shokor, Puererfellner, Helmut, Ravens, Ursula, Rienstra, Michiel, Sanders, Prashanthan, Scherr, Daniel, Schnabel, Renate, Schotten, Ulrich, Sohns, Christian, Steinbeck, Gerhard, Steven, Daniel, Toennis, Tobias, Tzeis, Stylianos, van Gelder, Isabelle C., van Leerdam, Roderick H., Vernooy, Kevin, Wadhwa, Manish, Wakili, Reza, Willems, Stephan, Witt, Henning, Zeemering, Stef, and Kirchho, Paulus
- Abstract
Aims Recent trial data demonstrate beneficial effects of active rhythm management in patients with atrial fibrillation (AF) and support the concept that a low arrhythmia burden is associated with a low risk of AF-related complications. The aim of this document is to summarize the key outcomes of the 9th AFNET/EHRA Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA) Methods Eighty-three international experts met in Münster for 2 days in September 2023. Key findings are as follows: (i) Active rhythm and results management should be part of the default initial treatment for all suitable patients with AF. (ii) Patients with device-detected AF have a low burden of AF and a low risk of stroke. Anticoagulation prevents some strokes and also increases major but non-lethal bleeding. (iii) More research is needed to improve stroke risk prediction in patients with AF, especially in those with a low AF burden. Biomolecules, genetics, and imaging can support this. (iv) The presence of AF should trigger systematic workup and comprehensive treatment of concomitant cardiovascular conditions. (v) Machine learning algorithms have been used to improve detection or likely development of AF. Cooperation between clinicians and data scientists is needed to leverage the potential of data science applications for patients with AF.Conclusions Patients with AF and a low arrhythmia burden have a lower risk of stroke and other cardiovascular events than those with a high arrhythmia burden. Combining active rhythm control, anticoagulation, rate control, and therapy of concomitant cardiovascular conditions can improve the lives of patients with AF.
- Published
- 2024
6. Longer and better lives for patients with atrial fibrillation : the 9th AFNET/EHRA consensus conference
- Author
-
Linz, Dominik, Andrade, Jason G., Arbelo, Elena, Boriani, Giuseppe, Breithardt, Guenter, Camm, A. John, Caso, Valeria, Nielsen, Jens Cosedis, De Melis, Mirko, De Potter, Tom, Dichtl, Wolfgang, Diederichsen, Søren Zoega, Dobrev, Dobromir, Doll, Nicolas, Duncker, David, Dworatzek, Elke, Eckardt, Lars, Eisert, Christoph, Fabritz, Larissa, Farkowski, Michal, Filgueiras-Rama, David, Goette, Andreas, Guasch, Eduard, Hack, Guido, Hatem, Stephane, Haeusler, Karl Georg, Healey, Jeff S., Heidbuechel, Hein, Hijazi, Ziad, Hofmeister, Lucas H., Hove-Madsen, Leif, Huebner, Thomas, Kääb, Stefan, Kotecha, Dipak, Malaczynska-Rajpold, Katarzyna, Merino, Jose Luis, Metzner, Andreas, Mont, Lluis, Ng, Ghulam Andre, Oeff, Michael, Parwani, Abdul Shokor, Puererfellner, Helmut, Ravens, Ursula, Rienstra, Michiel, Sanders, Prashanthan, Scherr, Daniel, Schnabel, Renate, Schotten, Ulrich, Sohns, Christian, Steinbeck, Gerhard, Steven, Daniel, Toennis, Tobias, Tzeis, Stylianos, van Gelder, Isabelle C., van Leerdam, Roderick H., Vernooy, Kevin, Wadhwa, Manish, Wakili, Reza, Willems, Stephan, Witt, Henning, Zeemering, Stef, Kirchhof, Paulus, Linz, Dominik, Andrade, Jason G., Arbelo, Elena, Boriani, Giuseppe, Breithardt, Guenter, Camm, A. John, Caso, Valeria, Nielsen, Jens Cosedis, De Melis, Mirko, De Potter, Tom, Dichtl, Wolfgang, Diederichsen, Søren Zoega, Dobrev, Dobromir, Doll, Nicolas, Duncker, David, Dworatzek, Elke, Eckardt, Lars, Eisert, Christoph, Fabritz, Larissa, Farkowski, Michal, Filgueiras-Rama, David, Goette, Andreas, Guasch, Eduard, Hack, Guido, Hatem, Stephane, Haeusler, Karl Georg, Healey, Jeff S., Heidbuechel, Hein, Hijazi, Ziad, Hofmeister, Lucas H., Hove-Madsen, Leif, Huebner, Thomas, Kääb, Stefan, Kotecha, Dipak, Malaczynska-Rajpold, Katarzyna, Merino, Jose Luis, Metzner, Andreas, Mont, Lluis, Ng, Ghulam Andre, Oeff, Michael, Parwani, Abdul Shokor, Puererfellner, Helmut, Ravens, Ursula, Rienstra, Michiel, Sanders, Prashanthan, Scherr, Daniel, Schnabel, Renate, Schotten, Ulrich, Sohns, Christian, Steinbeck, Gerhard, Steven, Daniel, Toennis, Tobias, Tzeis, Stylianos, van Gelder, Isabelle C., van Leerdam, Roderick H., Vernooy, Kevin, Wadhwa, Manish, Wakili, Reza, Willems, Stephan, Witt, Henning, Zeemering, Stef, and Kirchhof, Paulus
- Abstract
Aims: Recent trial data demonstrate beneficial effects of active rhythm management in patients with atrial fibrillation (AF) and support the concept that a low arrhythmia burden is associated with a low risk of AF-related complications. The aim of this document is to summarize the key outcomes of the 9th AFNET/EHRA Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Methods and results: Eighty-three international experts met in Munster for 2 days in September 2023. Key findings are as follows: (i) Active rhythm management should be part of the default initial treatment for all suitable patients with AF. (ii) Patients with device-detected AF have a low burden of AF and a low risk of stroke. Anticoagulation prevents some strokes and also increases major but non-lethal bleeding. (iii) More research is needed to improve stroke risk prediction in patients with AF, especially in those with a low AF burden. Biomolecules, genetics, and imaging can support this. (iv) The presence of AF should trigger systematic workup and comprehensive treatment of concomitant cardiovascular conditions. (v) Machine learning algorithms have been used to improve detection or likely development of AF. Cooperation between clinicians and data scientists is needed to leverage the potential of data science applications for patients with AF. Conclusions: Patients with AF and a low arrhythmia burden have a lower risk of stroke and other cardiovascular events than those with a high arrhythmia burden. Combining active rhythm control, anticoagulation, rate control, and therapy of concomitant cardiovascular conditions can improve the lives of patients with AF. Graphical Abstract
- Published
- 2024
- Full Text
- View/download PDF
7. Intramural Venous Ethanol Infusion for Refractory Ventricular Arrhythmias: Outcomes of a Multicenter Experience
- Author
-
Tavares, Liliana, Lador, Adi, Fuentes, Stephanie, Da-wariboko, Akanibo, Blaszyk, Krzysztof, Malaczynska-Rajpold, Katarzyna, Papiashvili, Giorgi, Korolev, Sergey, Peichl, Petr, Kautzner, Josef, Webber, Matthew, Hooks, Darren, Rodríguez-Mañero, Moisés, Di Toro, Darío, Labadet, Carlos, Sasaki, Takeshi, Okishige, Kaoru, Patel, Apoor, Schurmann, Paul A., Dave, Amish S., Rami, Tapan G., and Valderrábano, Miguel
- Published
- 2020
- Full Text
- View/download PDF
8. Antiplatelet and Anti-Coagulation Therapy for Left-Sided Catheter Ablations: What Is beyond Atrial Fibrillation?
- Author
-
Nesti, Martina, primary, Lucà, Fabiana, additional, Duncker, David, additional, De Sensi, Francesco, additional, Malaczynska-Rajpold, Katarzyna, additional, Behar, Jonathan M., additional, Waldmann, Victor, additional, Ammar, Ahmed, additional, Mirizzi, Gianluca, additional, Garcia, Rodrigue, additional, Arnold, Ahran, additional, Mikhaylov, Evgeny N., additional, Kosiuk, Jedrzej, additional, and Sciarra, Luigi, additional
- Published
- 2023
- Full Text
- View/download PDF
9. Electrophysiology fellowship experience and requirements: an EHRA survey
- Author
-
Linz, Dominik, primary, Chun, Julian, additional, Guerra, Federico, additional, Conte, Giulio, additional, Garcia, Rodrigue, additional, Kommata, Varvara, additional, Malaczynska-Rajpold, Katarzyna, additional, Nesti, Martina, additional, and Duncker, David, additional
- Published
- 2023
- Full Text
- View/download PDF
10. Red Blood Cells Distribution Width as a Potential Prognostic Biomarker in Patients With Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
- Author
-
Smukowska-Gorynia, Anna, Tomaszewska, Iga, Malaczynska-Rajpold, Katarzyna, Marcinkowska, Justyna, Komosa, Anna, Janus, Magdalena, Olasinska-Wisniewska, Anna, Slawek, Sylwia, Araszkiewicz, Aleksander, Jankiewicz, Stanislaw, and Mularek-Kubzdela, Tatiana
- Published
- 2018
- Full Text
- View/download PDF
11. Occupational Radiation Exposure of Electrophysiology Staff with Reproductive Potential and During Pregnancy – EHRA Survey
- Author
-
Adeliño, Raquel, primary, Malaczynska-Rajpold, Katarzyna, additional, Perrotta, Laura, additional, Manninger, Martin, additional, Vanduynhoven, Philippe, additional, Nesti, Martina, additional, Goanță, Emilia-Violeta, additional, Waldmann, Victor, additional, Pavlovic, Nikola, additional, Farkowski, Michal M, additional, Guerra, Jose M, additional, Penela, Diego, additional, Boveda, Serge, additional, and Chun, Julian K R, additional
- Published
- 2023
- Full Text
- View/download PDF
12. Electrophysiology fellowship experience and requirements : an EHRA survey
- Author
-
Linz, Dominik, Chun, Julian, Guerra, Federico, Conte, Giulio, Garcia, Rodrigue, Kommata, Varvara, Malaczynska-Rajpold, Katarzyna, Nesti, Martina, Duncker, David, Linz, Dominik, Chun, Julian, Guerra, Federico, Conte, Giulio, Garcia, Rodrigue, Kommata, Varvara, Malaczynska-Rajpold, Katarzyna, Nesti, Martina, and Duncker, David
- Abstract
Aims This study aims to survey current educational experience and the individual requirements for electrophysiologists in training. Methods and results The European Heart Rhythm Association (EHRA) e-Communication Committee and the Scientific Initiatives Committee prepared a questionnaire and distributed it via newsletters, Twitter, LinkedIn, and Facebook. The survey consisted of 22 questions collected on an individual basis anonymously. Two hundred and forty-three responders from 35 countries (32% female, age 38 ± 6 years old) completed the survey. This EHRA electrophysiology (EP) fellowship survey showed that (i) hands-on participation and observation of EP procedures are very important; (ii) the main motivations to choose the EP fellowship institution are centre reputation and volume as well as the availability of a structured EP fellowship programme; (iii) 59% passed the EHRA exam and 46% took a national certification exam; (iv) respondents are overall satisfied with their own fellowships, but there are areas of less confidence such as conduction system pacing implantation and cardiac resynchronization therapy implantation; (v) 78% of respondents performed research during their fellowship, (vi) the optimal duration of an EP fellowship should be at least 2 years; and (viii) doing fellowships abroad is beneficial, but significant obstacles exist. Conclusion The results of this EHRA survey may help to refine current EP fellowship programmes to improve the quality of EP training and early career building of young electrophysiologists.
- Published
- 2023
- Full Text
- View/download PDF
13. Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation : the 8th AFNET/EHRA consensus conference
- Author
-
Schnabel, Renate B, Marinelli, Elena Andreassi, Arbelo, Elena, Boriani, Giuseppe, Boveda, Serge, Buckley, Claire M, Camm, A John, Casadei, Barbara, Chua, Winnie, Dagres, Nikolaos, de Melis, Mirko, Desteghe, Lien, Diederichsen, Søren Zöga, Duncker, David, Eckardt, Lars, Eisert, Christoph, Engler, Daniel, Fabritz, Larissa, Freedman, Ben, Gillet, Ludovic, Goette, Andreas, Guasch, Eduard, Svendsen, Jesper Hastrup, Hatem, Stéphane N, Haeusler, Karl Georg, Healey, Jeff S, Heidbuchel, Hein, Hindricks, Gerhard, Hobbs, F D Richard, Hübner, Thomas, Kotecha, Dipak, Krekler, Michael, Leclercq, Christophe, Lewalter, Thorsten, Lin, Honghuang, Linz, Dominik, Lip, Gregory Y H, Løchen, Maja Lisa, Lucassen, Wim, Malaczynska-Rajpold, Katarzyna, Massberg, Steffen, Merino, Jose L, Meyer, Ralf, Mont, Lluıs, Myers, Michael C, Neubeck, Lis, Niiranen, Teemu, Oeff, Michael, Oldgren, Jonas, Potpara, Tatjana S, Psaroudakis, George, Pürerfellner, Helmut, Ravens, Ursula, Rienstra, Michiel, Rivard, Lena, Scherr, Daniel, Schotten, Ulrich, Shah, Dipen, Sinner, Moritz F, Smolnik, Rüdiger, Steinbeck, Gerhard, Steven, Daniel, Svennberg, Emma, Thomas, Dierk, True Hills, Mellanie, van Gelder, Isabelle C, Vardar, Burcu, Palà, Elena, Wakili, Reza, Wegscheider, Karl, Wieloch, Mattias, Willems, Stephan, Witt, Henning, Ziegler, André, Daniel Zink, Matthias, Kirchhof, Paulus, Schnabel, Renate B, Marinelli, Elena Andreassi, Arbelo, Elena, Boriani, Giuseppe, Boveda, Serge, Buckley, Claire M, Camm, A John, Casadei, Barbara, Chua, Winnie, Dagres, Nikolaos, de Melis, Mirko, Desteghe, Lien, Diederichsen, Søren Zöga, Duncker, David, Eckardt, Lars, Eisert, Christoph, Engler, Daniel, Fabritz, Larissa, Freedman, Ben, Gillet, Ludovic, Goette, Andreas, Guasch, Eduard, Svendsen, Jesper Hastrup, Hatem, Stéphane N, Haeusler, Karl Georg, Healey, Jeff S, Heidbuchel, Hein, Hindricks, Gerhard, Hobbs, F D Richard, Hübner, Thomas, Kotecha, Dipak, Krekler, Michael, Leclercq, Christophe, Lewalter, Thorsten, Lin, Honghuang, Linz, Dominik, Lip, Gregory Y H, Løchen, Maja Lisa, Lucassen, Wim, Malaczynska-Rajpold, Katarzyna, Massberg, Steffen, Merino, Jose L, Meyer, Ralf, Mont, Lluıs, Myers, Michael C, Neubeck, Lis, Niiranen, Teemu, Oeff, Michael, Oldgren, Jonas, Potpara, Tatjana S, Psaroudakis, George, Pürerfellner, Helmut, Ravens, Ursula, Rienstra, Michiel, Rivard, Lena, Scherr, Daniel, Schotten, Ulrich, Shah, Dipen, Sinner, Moritz F, Smolnik, Rüdiger, Steinbeck, Gerhard, Steven, Daniel, Svennberg, Emma, Thomas, Dierk, True Hills, Mellanie, van Gelder, Isabelle C, Vardar, Burcu, Palà, Elena, Wakili, Reza, Wegscheider, Karl, Wieloch, Mattias, Willems, Stephan, Witt, Henning, Ziegler, André, Daniel Zink, Matthias, and Kirchhof, Paulus
- Abstract
Despite marked progress in the management of atrial fibrillation (AF), detecting AF remains difficult and AF-related complications cause unacceptable morbidity and mortality even on optimal current therapy. This document summarizes the key outcomes of the 8th AFNET/EHRA Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Eighty-three international experts met in Hamburg for 2 days in October 2021. Results of the interdisciplinary, hybrid discussions in breakout groups and the plenary based on recently published and unpublished observations are summarized in this consensus paper to support improved care for patients with AF by guiding prevention, individualized management, and research strategies. The main outcomes are (i) new evidence supports a simple, scalable, and pragmatic population-based AF screening pathway; (ii) rhythm management is evolving from therapy aimed at improving symptoms to an integrated domain in the prevention of AF-related outcomes, especially in patients with recently diagnosed AF; (iii) improved characterization of atrial cardiomyopathy may help to identify patients in need for therapy; (iv) standardized assessment of cognitive function in patients with AF could lead to improvement in patient outcomes; and (v) artificial intelligence (AI) can support all of the above aims, but requires advanced interdisciplinary knowledge and collaboration as well as a better medico-legal framework. Implementation of new evidence-based approaches to AF screening and rhythm management can improve outcomes in patients with AF. Additional benefits are possible with further efforts to identify and target atrial cardiomyopathy and cognitive impairment, which can be facilitated by AI.
- Published
- 2023
- Full Text
- View/download PDF
14. Electrophysiology fellowship experience and requirements:an EHRA survey
- Author
-
Linz, Dominik, Chun, Julian, Guerra, Federico, Conte, Giulio, Garcia, Rodrigue, Kommata, Varvara, Malaczynska-Rajpold, Katarzyna, Nesti, Martina, Duncker, David, Linz, Dominik, Chun, Julian, Guerra, Federico, Conte, Giulio, Garcia, Rodrigue, Kommata, Varvara, Malaczynska-Rajpold, Katarzyna, Nesti, Martina, and Duncker, David
- Abstract
AIMS: This study aims to survey current educational experience and the individual requirements for electrophysiologists in training. METHODS AND RESULTS: The European Heart Rhythm Association (EHRA) e-Communication Committee and the Scientific Initiatives Committee prepared a questionnaire and distributed it via newsletters, Twitter, LinkedIn, and Facebook. The survey consisted of 22 questions collected on an individual basis anonymously. Two hundred and forty-three responders from 35 countries (32% female, age 38 ± 6 years old) completed the survey. This EHRA electrophysiology (EP) fellowship survey showed that (i) hands-on participation and observation of EP procedures are very important; (ii) the main motivations to choose the EP fellowship institution are centre reputation and volume as well as the availability of a structured EP fellowship programme; (iii) 59% passed the EHRA exam and 46% took a national certification exam; (iv) respondents are overall satisfied with their own fellowships, but there are areas of less confidence such as conduction system pacing implantation and cardiac resynchronization therapy implantation; (v) 78% of respondents performed research during their fellowship, (vi) the optimal duration of an EP fellowship should be at least 2 years; and (viii) doing fellowships abroad is beneficial, but significant obstacles exist. CONCLUSION: The results of this EHRA survey may help to refine current EP fellowship programmes to improve the quality of EP training and early career building of young electrophysiologists.
- Published
- 2023
15. Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation:the 8th AFNET/EHRA consensus conference
- Author
-
Schnabel, Renate B., Marinelli, Elena Andreassi, Arbelo, Elena, Boriani, Giuseppe, Boveda, Serge, Buckley, Claire M., Camm, A. John, Casadei, Barbara, Chua, Winnie, Dagres, Nikolaos, de Melis, Mirko, Desteghe, Lien, Diederichsen, Soren Zoga, Duncker, David, Eckardt, Lars, Eisert, Christoph, Engler, Daniel, Fabritz, Larissa, Freedman, Ben, Gillet, Ludovic, Goette, Andreas, Guasch, Eduard, Svendsen, Jesper Hastrup, Hatem, Stephane N., Haeusler, Karl Georg, Healey, Jeff S., Heidbuchel, Hein, Hindricks, Gerhard, Hobbs, F. D. Richard, Huebner, Thomas, Kotecha, Dipak, Krekler, Michael, Leclercq, Christophe, Lewalter, Thorsten, Lin, Honghuang, Linz, Dominik, Lip, Gregory Y. H., Lochen, Maja Lisa, Lucassen, Wim, Malaczynska-Rajpold, Katarzyna, Massberg, Steffen, Merino, Jose L., Meyer, Ralf, Mont, Lluis, Myers, Michael C., Neubeck, Lis, Niiranen, Teemu, Oeff, Michael, Oldgren, Jonas, Potpara, Tatjana S., Psaroudakis, George, Purerfellner, Helmut, Ravens, Ursula, Rienstra, Michiel, Rivard, Lena, Scherr, Daniel, Schotten, Ulrich, Shah, Dipen, Sinner, Moritz F., Smolnik, Rudiger, Steinbeck, Gerhard, Steven, Daniel, Svennberg, Emma, Thomas, Dierk, Hills, Mellanie True, van Gelder, Isabelle C., Vardar, Burcu, Pala, Elena, Wakili, Reza, Wegscheider, Karl, Wieloch, Mattias, Willems, Stephan, Witt, Henning, Ziegler, Andre, Zink, Matthias Daniel, Kirchhof, Paulus, Schnabel, Renate B., Marinelli, Elena Andreassi, Arbelo, Elena, Boriani, Giuseppe, Boveda, Serge, Buckley, Claire M., Camm, A. John, Casadei, Barbara, Chua, Winnie, Dagres, Nikolaos, de Melis, Mirko, Desteghe, Lien, Diederichsen, Soren Zoga, Duncker, David, Eckardt, Lars, Eisert, Christoph, Engler, Daniel, Fabritz, Larissa, Freedman, Ben, Gillet, Ludovic, Goette, Andreas, Guasch, Eduard, Svendsen, Jesper Hastrup, Hatem, Stephane N., Haeusler, Karl Georg, Healey, Jeff S., Heidbuchel, Hein, Hindricks, Gerhard, Hobbs, F. D. Richard, Huebner, Thomas, Kotecha, Dipak, Krekler, Michael, Leclercq, Christophe, Lewalter, Thorsten, Lin, Honghuang, Linz, Dominik, Lip, Gregory Y. H., Lochen, Maja Lisa, Lucassen, Wim, Malaczynska-Rajpold, Katarzyna, Massberg, Steffen, Merino, Jose L., Meyer, Ralf, Mont, Lluis, Myers, Michael C., Neubeck, Lis, Niiranen, Teemu, Oeff, Michael, Oldgren, Jonas, Potpara, Tatjana S., Psaroudakis, George, Purerfellner, Helmut, Ravens, Ursula, Rienstra, Michiel, Rivard, Lena, Scherr, Daniel, Schotten, Ulrich, Shah, Dipen, Sinner, Moritz F., Smolnik, Rudiger, Steinbeck, Gerhard, Steven, Daniel, Svennberg, Emma, Thomas, Dierk, Hills, Mellanie True, van Gelder, Isabelle C., Vardar, Burcu, Pala, Elena, Wakili, Reza, Wegscheider, Karl, Wieloch, Mattias, Willems, Stephan, Witt, Henning, Ziegler, Andre, Zink, Matthias Daniel, and Kirchhof, Paulus
- Abstract
Aims Despite marked progress in the management of atrial fibrillation (AF), detecting AF remains difficult and AF-related complications cause unacceptable morbidity and mortality even on optimal current therapy. Methods and results This document summarizes the key outcomes of the 8th AFNET/EHRA Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Eighty-three international experts met in Hamburg for 2 days in October 2021. Results of the interdisciplinary, hybrid discussions in breakout groups and the plenary based on recently published and unpublished observations are summarized in this consensus paper to support improved care for patients with AF by guiding prevention, individualized management, and research strategies. The main outcomes are (i) new evidence supports a simple, scalable, and pragmatic population-based AF screening pathway; (ii) rhythm management is evolving from therapy aimed at improving symptoms to an integrated domain in the prevention of AF-related outcomes, especially in patients with recently diagnosed AF; (iii) improved characterization of atrial cardiomyopathy may help to identify patients in need for therapy; (iv) standardized assessment of cognitive function in patients with AF could lead to improvement in patient outcomes; and (v) artificial intelligence (AI) can support all of the above aims, but requires advanced interdisciplinary knowledge and collaboration as well as a better medico-legal framework. Conclusions Implementation of new evidence-based approaches to AF screening and rhythm management can improve outcomes in patients with AF. Additional benefits are possible with further efforts to identify and target atrial cardiomyopathy and cognitive impairment, which can be facilitated by AI.
- Published
- 2023
16. The Management of Supraventricular Tachyarrhythmias in Patients with Pulmonary Arterial Hypertension
- Author
-
Małaczyńska-Rajpold, Katarzyna, Komosa, Anna, Błaszyk, Krzysztof, Araszkiewicz, Aleksander, Janus, Magdalena, Olasińska-Wiśniewska, Anna, Jankiewicz, Stanisław, Mączyński, Maciej, and Mularek-Kubzdela, Tatiana
- Published
- 2016
- Full Text
- View/download PDF
17. Erratum: How to use digital devices to detect and manage arrhythmias: an EHRA practical guide (EP Europace (2022) 24:6 (979-1005) DOI: 10.1093/europace/euac038)
- Author
-
Svennberg, Emma, Tjong, Fleur, Goette, Andreas, Akoum, Nazem, di Biase, Luigi, Bordachar, Pierre, Boriani, Giuseppe, Burri, Haran, Conte, Giulio, Deharo, Jean Claude, Deneke, Thomas, Drossart, Inga, Duncker, David, Han, Janet K., Heidbuchel, Hein, Jais, Pierre, de Oliveira Figueiredo, Marcio Jansen, Linz, Dominik, Lip, Gregory Y. H., Malaczynska-Rajpold, Katarzyna, Márquez, Manlio F., Ploem, Corrette, Soejima, Kyoko, Stiles, Martin K., Wierda, Eric, Vernooy, Kevin, Leclercq, Christophe, Meyer, Christian, Pisani, Cristiano, Pak, Hui Nam, Gupta, Dhiraj, Pürerfellner, Helmut, Crijns, H. J. G. M., Chavez, Edgar Antezana, Willems, Stephan, Waldmann, Victor, Dekker, Lukas, Wan, Elaine, Kavoor, Pramesh, Turagam, Mohit K., Sinner, Moritz, Cardiology, ACS - Heart failure & arrhythmias, Ethics, Law & Medical humanities, APH - Digital Health, and APH - Personalized Medicine
- Abstract
In the originally published version of this manuscript, the names of authors Marcio Jansen de Oliveira Figueiredo and Manlio F. Márquez were incorrectly given. Both names have now been corrected online. In addition, the following affiliation was inadvertently omitted for author Manlio F. Márquez: Cardiology, Electrophysiology Service, American British Cowdray Medical Center, Mexico City, México This affiliation has now been added to the online version of the manuscript as affiliation 27 and all subsequent affiliations in this manuscript affected by this change have been updated accordingly.
- Published
- 2023
18. Occupational radiation exposure of electrophysiology staff with reproductive potential and during pregnancy: an EHRA survey.
- Author
-
Adeliño, Raquel, Malaczynska-Rajpold, Katarzyna, Perrotta, Laura, Manninger, Martin, Vanduynhoven, Philippe, Nesti, Martina, Goanță, Emilia-Violeta, Waldmann, Victor, Pavlovic, Nikola, Farkowski, Michal M, Guerra, Jose M, Penela, Diego, Boveda, Serge, and Chun, Julian K R
- Abstract
Aims Electrophysiology (EP) is a growing field in cardiology, with an increasing involvement of young people. Nevertheless, concerns about radiation exposure and its impact on reproduction and pregnancy may discourage the choice of an EP career. The study is aimed at investigating the level of awareness and main sources of concern about the effects of radiation on reproductive potential and pregnancy, exploring the safety measures adopted in different EP labs, and verifying the adherence to the current guidelines. Methods and results An online survey was conducted using the European Heart Rhythm Association (EHRA) infrastructure from April to June 2022. A total of 252 EP personnel (42% women) participated, from 50 countries and different professional roles. Most participants expressed concerns regarding the effects of radiation on reproductive capacity (67.1%) and offspring diseases (68.2%). Only 37.9% of participants were aware of the EHRA 2017 consensus document about occupational radiation exposure. Most participants (80.9%) considered that occupational radiation during pregnancy is not safe. EP female staff were not allowed to work in the EP lab during pregnancy in 48.1% of cases. Zero-fluoroscopy was the preferred choice to continue working in the EP lab during pregnancy. Conclusion EP staff, including both men and women, have concerns about the effects of radiation on reproductive capacity. Despite the recommendations issued by international bodies, implementation of the policies regarding pregnancy and occupational radiation exposure is heterogeneous. Zero-fluoroscopy is the preferred approach to ensure safety during pregnancy in the EP lab. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
19. Leadless Cardiac Pacing: New Horizons
- Author
-
Malaczynska-Rajpold, Katarzyna, primary, Elliot, Mark, additional, Wijesuriya, Nadeev, additional, Mehta, Vishal, additional, Wong, Tom, additional, Rinaldi, Christopher Aldo, additional, and Behar, Jonathan M., additional
- Published
- 2022
- Full Text
- View/download PDF
20. Left Bundle Area Pacing for Tachycardia-Bradycardia Syndrome in a Patient With Dextrocardia
- Author
-
Bodagh, Neil, primary, Malaczynska-Rajpold, Katarzyna, additional, Eysenck, William, additional, O’Connor, Matthew, additional, and Wong, Tom, additional
- Published
- 2022
- Full Text
- View/download PDF
21. Reimbursement practices for use of digital devices in atrial fibrillation and other arrhythmias: a European Heart Rhythm Association survey
- Author
-
Boriani, Giuseppe, primary, Svennberg, Emma, additional, Guerra, Federico, additional, Linz, Dominik, additional, Casado-Arroyo, Ruben, additional, Malaczynska-Rajpold, Katarzyna, additional, Duncker, David, additional, Boveda, Serge, additional, Merino, Josè Luis, additional, and Leclercq, Christophe, additional
- Published
- 2022
- Full Text
- View/download PDF
22. Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference
- Author
-
Schnabel, Renate B, primary, Marinelli, Elena Andreassi, additional, Arbelo, Elena, additional, Boriani, Giuseppe, additional, Boveda, Serge, additional, Buckley, Claire M, additional, Camm, A John, additional, Casadei, Barbara, additional, Chua, Winnie, additional, Dagres, Nikolaos, additional, de Melis, Mirko, additional, Desteghe, Lien, additional, Diederichsen, Søren Zöga, additional, Duncker, David, additional, Eckardt, Lars, additional, Eisert, Christoph, additional, Engler, Daniel, additional, Fabritz, Larissa, additional, Freedman, Ben, additional, Gillet, Ludovic, additional, Goette, Andreas, additional, Guasch, Eduard, additional, Svendsen, Jesper Hastrup, additional, Hatem, Stéphane N, additional, Haeusler, Karl Georg, additional, Healey, Jeff S, additional, Heidbuchel, Hein, additional, Hindricks, Gerhard, additional, Hobbs, F D Richard, additional, Hübner, Thomas, additional, Kotecha, Dipak, additional, Krekler, Michael, additional, Leclercq, Christophe, additional, Lewalter, Thorsten, additional, Lin, Honghuang, additional, Linz, Dominik, additional, Lip, Gregory Y H, additional, Løchen, Maja Lisa, additional, Lucassen, Wim, additional, Malaczynska-Rajpold, Katarzyna, additional, Massberg, Steffen, additional, Merino, Jose L, additional, Meyer, Ralf, additional, Mont, Lluıs, additional, Myers, Michael C, additional, Neubeck, Lis, additional, Niiranen, Teemu, additional, Oeff, Michael, additional, Oldgren, Jonas, additional, Potpara, Tatjana S, additional, Psaroudakis, George, additional, Pürerfellner, Helmut, additional, Ravens, Ursula, additional, Rienstra, Michiel, additional, Rivard, Lena, additional, Scherr, Daniel, additional, Schotten, Ulrich, additional, Shah, Dipen, additional, Sinner, Moritz F, additional, Smolnik, Rüdiger, additional, Steinbeck, Gerhard, additional, Steven, Daniel, additional, Svennberg, Emma, additional, Thomas, Dierk, additional, True Hills, Mellanie, additional, van Gelder, Isabelle C, additional, Vardar, Burcu, additional, Palà, Elena, additional, Wakili, Reza, additional, Wegscheider, Karl, additional, Wieloch, Mattias, additional, Willems, Stephan, additional, Witt, Henning, additional, Ziegler, André, additional, Daniel Zink, Matthias, additional, and Kirchhof, Paulus, additional
- Published
- 2022
- Full Text
- View/download PDF
23. PO-05-096 LEARNING BEFORE BURNING: IMPACT OF SIMULATOR EXPOSURE ON CLINICAL ELECTROPHYSIOLOGY EDUCATION
- Author
-
Jadczyk, Tomasz, Malaczynska-Rajpold, Katarzyna, Narayanan, Kumar, Kosiuk, Jedrzej, Kozlik, Maciej, Cogiel, Michal, Kost, Jan, Hemmerling, Daria, Staniszewski, Michal, Szczesna, Agnieszka, Wojakowski, Wojciech, Sauer, William H., and Zei, Paul C.
- Published
- 2024
- Full Text
- View/download PDF
24. Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation : the 8th AFNET/EHRA consensus conference.
- Author
-
Schnabel, Renate B, Marinelli, Elena Andreassi, Arbelo, Elena, Boriani, Giuseppe, Boveda, Serge, Buckley, Claire M, Camm, A John, Casadei, Barbara, Chua, Winnie, Dagres, Nikolaos, de Melis, Mirko, Desteghe, Lien, Diederichsen, Søren Zöga, Duncker, David, Eckardt, Lars, Eisert, Christoph, Engler, Daniel, Fabritz, Larissa, Freedman, Ben, Gillet, Ludovic, Goette, Andreas, Guasch, Eduard, Svendsen, Jesper Hastrup, Hatem, Stéphane N, Haeusler, Karl Georg, Healey, Jeff S, Heidbuchel, Hein, Hindricks, Gerhard, Hobbs, F D Richard, Hübner, Thomas, Kotecha, Dipak, Krekler, Michael, Leclercq, Christophe, Lewalter, Thorsten, Lin, Honghuang, Linz, Dominik, Lip, Gregory Y H, Løchen, Maja Lisa, Lucassen, Wim, Malaczynska-Rajpold, Katarzyna, Massberg, Steffen, Merino, Jose L, Meyer, Ralf, Mont, Lluıs, Myers, Michael C, Neubeck, Lis, Niiranen, Teemu, Oeff, Michael, Oldgren, Jonas, Potpara, Tatjana S, Psaroudakis, George, Pürerfellner, Helmut, Ravens, Ursula, Rienstra, Michiel, Rivard, Lena, Scherr, Daniel, Schotten, Ulrich, Shah, Dipen, Sinner, Moritz F, Smolnik, Rüdiger, Steinbeck, Gerhard, Steven, Daniel, Svennberg, Emma, Thomas, Dierk, True Hills, Mellanie, van Gelder, Isabelle C, Vardar, Burcu, Palà, Elena, Wakili, Reza, Wegscheider, Karl, Wieloch, Mattias, Willems, Stephan, Witt, Henning, Ziegler, André, Daniel Zink, Matthias, Kirchhof, Paulus, Schnabel, Renate B, Marinelli, Elena Andreassi, Arbelo, Elena, Boriani, Giuseppe, Boveda, Serge, Buckley, Claire M, Camm, A John, Casadei, Barbara, Chua, Winnie, Dagres, Nikolaos, de Melis, Mirko, Desteghe, Lien, Diederichsen, Søren Zöga, Duncker, David, Eckardt, Lars, Eisert, Christoph, Engler, Daniel, Fabritz, Larissa, Freedman, Ben, Gillet, Ludovic, Goette, Andreas, Guasch, Eduard, Svendsen, Jesper Hastrup, Hatem, Stéphane N, Haeusler, Karl Georg, Healey, Jeff S, Heidbuchel, Hein, Hindricks, Gerhard, Hobbs, F D Richard, Hübner, Thomas, Kotecha, Dipak, Krekler, Michael, Leclercq, Christophe, Lewalter, Thorsten, Lin, Honghuang, Linz, Dominik, Lip, Gregory Y H, Løchen, Maja Lisa, Lucassen, Wim, Malaczynska-Rajpold, Katarzyna, Massberg, Steffen, Merino, Jose L, Meyer, Ralf, Mont, Lluıs, Myers, Michael C, Neubeck, Lis, Niiranen, Teemu, Oeff, Michael, Oldgren, Jonas, Potpara, Tatjana S, Psaroudakis, George, Pürerfellner, Helmut, Ravens, Ursula, Rienstra, Michiel, Rivard, Lena, Scherr, Daniel, Schotten, Ulrich, Shah, Dipen, Sinner, Moritz F, Smolnik, Rüdiger, Steinbeck, Gerhard, Steven, Daniel, Svennberg, Emma, Thomas, Dierk, True Hills, Mellanie, van Gelder, Isabelle C, Vardar, Burcu, Palà, Elena, Wakili, Reza, Wegscheider, Karl, Wieloch, Mattias, Willems, Stephan, Witt, Henning, Ziegler, André, Daniel Zink, Matthias, and Kirchhof, Paulus
- Abstract
AIMS: Despite marked progress in the management of atrial fibrillation (AF), detecting AF remains difficult and AF-related complications cause unacceptable morbidity and mortality even on optimal current therapy. METHODS AND RESULTS: This document summarizes the key outcomes of the 8th AFNET/EHRA Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Eighty-three international experts met in Hamburg for 2 days in October 2021. Results of the interdisciplinary, hybrid discussions in breakout groups and the plenary based on recently published and unpublished observations are summarized in this consensus paper to support improved care for patients with AF by guiding prevention, individualized management, and research strategies. The main outcomes are (i) new evidence supports a simple, scalable, and pragmatic population-based AF screening pathway; (ii) rhythm management is evolving from therapy aimed at improving symptoms to an integrated domain in the prevention of AF-related outcomes, especially in patients with recently diagnosed AF; (iii) improved characterization of atrial cardiomyopathy may help to identify patients in need for therapy; (iv) standardized assessment of cognitive function in patients with AF could lead to improvement in patient outcomes; and (v) artificial intelligence (AI) can support all of the above aims, but requires advanced interdisciplinary knowledge and collaboration as well as a better medico-legal framework. CONCLUSIONS: Implementation of new evidence-based approaches to AF screening and rhythm management can improve outcomes in patients with AF. Additional benefits are possible with further efforts to identify and target atrial cardiomyopathy and cognitive impairment, which can be facilitated by AI.
- Published
- 2022
- Full Text
- View/download PDF
25. Reimbursement practices for use of digital devices in atrial fibrillation and other arrhythmias: a European Heart Rhythm Association survey.
- Author
-
Boriani, Giuseppe, Svennberg, Emma, Guerra, Federico, Linz, Dominik, Casado Arroyo, Ruben, Malaczynska-Rajpold, Katarzyna, Duncker, David, Boveda, Serge, Merino, José Luis, Leclercq, Christophe, Boriani, Giuseppe, Svennberg, Emma, Guerra, Federico, Linz, Dominik, Casado Arroyo, Ruben, Malaczynska-Rajpold, Katarzyna, Duncker, David, Boveda, Serge, Merino, José Luis, and Leclercq, Christophe
- Abstract
Since digital devices are increasingly used in cardiology for assessing cardiac rhythm and detecting arrhythmias, especially atrial fibrillation (AF), our aim was to evaluate the expectations and opinions of healthcare professionals in Europe on reimbursement policies for the use of digital devices (including wearables) in AF and other arrhythmias. An anonymous survey was proposed through announcements on the European Heart Rhythm Association website, social media channels, and mail newsletter. Two hundred and seventeen healthcare professionals participated in the survey: 32.7%, reported regular use of digital devices, 45.2% reported that they sometimes use these tools, 18.6% that they do not use but would like to. Only a minority (3.5%) reported a lack of trust in digital devices. The survey highlighted a general propensity to provide medical consultation for suspected AF or other arrhythmias detected by a consumer-initiated use of digital devices, even if time constraints and reimbursement availability emerged as important elements. More than 85% of respondents agreed that reimbursement should be applied for clinical use of digital devices, also in different settings such as post-stroke, post-cardioversion, post-ablation, and in patients with palpitations or syncope. Finally, 73.6% of respondents confirmed a lack of reimbursement fees in their country for physicians' consultations (tracings interpretation) related to digital devices. Digital devices, including wearables, are increasingly and widely used for assessing cardiac rhythm and detecting AF, but a definition of reimbursement policies for physicians' consultations is needed., SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2022
26. How to use digital devices to detect and manage arrhythmias: an EHRA practical guide
- Author
-
Svennberg, Emma, primary, Tjong, Fleur, additional, Goette, Andreas, additional, Akoum, Nazem, additional, Di Biase, Luigi, additional, Bordachar, Pierre, additional, Boriani, Giuseppe, additional, Burri, Haran, additional, Conte, Giulio, additional, Deharo, Jean Claude, additional, Deneke, Thomas, additional, Drossart, Inga, additional, Duncker, David, additional, Han, Janet K, additional, Heidbuchel, Hein, additional, Jais, Pierre, additional, de Oliveira Figueiredo, Marcio Jansen, additional, Linz, Dominik, additional, Lip, Gregory Y H, additional, Malaczynska-Rajpold, Katarzyna, additional, Márquez, Manlio F, additional, Ploem, Corrette, additional, Soejima, Kyoko, additional, Stiles, Martin K, additional, Wierda, Eric, additional, Vernooy, Kevin, additional, Leclercq, Christophe, additional, Meyer, Christian, additional, Pisani, Cristiano, additional, Pak, Hui Nam, additional, Gupta, Dhiraj, additional, Pürerfellner, Helmut, additional, Crijns, H J G M, additional, Chavez, Edgar Antezana, additional, Willems, Stephan, additional, Waldmann, Victor, additional, Dekker, Lukas, additional, Wan, Elaine, additional, Kavoor, Pramesh, additional, Turagam, Mohit K, additional, and Sinner, Moritz, additional
- Published
- 2022
- Full Text
- View/download PDF
27. Acute and Long-Term Scar Characterization of Venous Ethanol Ablation in the Left Ventricular Summit
- Author
-
Fuentes Rojas, Stephanie Claribel, primary, Malahfji, Maan, additional, Tavares, Liliana, additional, Patel, Apoor, additional, Schurmann, Paul Antonio, additional, Dave, Amish, additional, Tapias, Carlos, additional, Rodriguez, Diego, additional, Sáenz Morales, Luis Carlos, additional, Korolev, Sergei, additional, Papiashvili, Giorgi, additional, Peichl, Petr, additional, Kautzner, Josef, additional, Blaszyk, Krzysztof, additional, Malaczynska-Rajpold, Katarzyna, additional, Chen, Tiffany, additional, Santangeli, Pasquale, additional, Shah, Dipan J., additional, and Valderrábano, Miguel, additional
- Published
- 2022
- Full Text
- View/download PDF
28. The interpretation of CHA2DS2-VASc score components in clinical practice: a joint survey by the European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, the EHRA Young Electrophysiologists, the Association of Cardiovascular Nursing and Allied Professionals, and the European Society of Cardiology Council on Stroke
- Author
-
Zhang, Juqian, primary, Lenarczyk, Radoslaw, additional, Marin, Francisco, additional, Malaczynska-Rajpold, Katarzyna, additional, Kosiuk, Jedrzej, additional, Doehner, Wolfram, additional, Van Gelder, Isabelle C, additional, Lee, Geraldine, additional, Hendriks, Jeroen M, additional, Lip, Gregory Y H, additional, and Potpara, Tatjana S, additional
- Published
- 2020
- Full Text
- View/download PDF
29. Islets of heterogeneous myocardium within the scar in cardiac magnetic resonance predict ventricular tachycardia after myocardial infarction
- Author
-
Malaczynska‐Rajpold, Katarzyna, primary, Blaszyk, Krzysztof, additional, Kociemba, Anna, additional, Pyda, Malgorzata, additional, Posadzy‐Malaczynska, Anna, additional, and Grajek, Stefan, additional
- Published
- 2020
- Full Text
- View/download PDF
30. The interpretation of CHA2DS2-VASc score components in clinical practice: a joint survey by the European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, the EHRA Young Electrophysiologists, the Association of Cardiovascular Nursing and Allied Professionals, and the European Society of Cardiology Council on Stroke.
- Author
-
Zhang, Juqian, Lenarczyk, Radoslaw, Marin, Francisco, Malaczynska-Rajpold, Katarzyna, Kosiuk, Jedrzej, Doehner, Wolfram, Gelder, Isabelle C Van, Lee, Geraldine, Hendriks, Jeroen M, Lip, Gregory Y H, Potpara, Tatjana S, and Van Gelder, Isabelle C
- Abstract
This European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, EHRA Young Electrophysiologists, Association of Cardiovascular Nursing and Allied Professionals, and European Society of Cardiology (ESC) Council on Stroke joint survey aimed to assess the interpretation of the CHA2DS2-VASc score components and preferred resources for calculating the score. Of 439 respondents, most were general cardiologists (46.7%) or electrophysiologists (EPs) (42.1%). The overall adherence to the ESC-defined scoring criteria was good. Most variation was observed in the interpretation of the significance of left ventricular ejection fraction and brain natriuretic peptide in the scoring for the 'C' component, as well as the 'one-off high reading of blood pressure' to score on the 'H' component. Greater confidence was expressed in scoring the 'H' component (72.3%) compared with the 'C' (46.2%) and 'V' (45.9%) components. Respondents mainly relied on their recall for the scoring of CHA2DS2-VASc score (64.2%). The three most favoured referencing resources varied among different professionals, with pharmacists and physicians relying mainly on memory or web/mobile app, whereas nurses favoured using a web/mobile app followed by memory or guidelines/protocol. In conclusion, this survey revealed overall good adherence to the correct definition of each component in scoring of the 'C', 'H', and 'V' elements of the CHA2DS2-VASc score, although the variation in their interpretations warrants further clarifications. The preferred referencing resources to calculate the score varied among different healthcare professionals. Guideline education to healthcare professionals and updated and unified online/mobile scoring tools are suggested to improve the accuracy in scoring the CHA2DS2-VASc score. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
31. The Polish adaptation of the CAMbridge Pulmonary Hypertension Outcome Review (CAMPHOR).
- Author
-
Malaczynska-Rajpold, Katarzyna, Smukowska-Gorynia, Anna, Heaney, Alice, McKenna, Stephen I. P., Janus, Magdalena, Araszkiewicz, Aleksander, Jankiewicz, Stanislaw, Slawek-Szmyt, Sylwia, Tomaszewska, Iga, and Mularek-Kubzdela, Tatiana
- Published
- 2020
- Full Text
- View/download PDF
32. Neopterin as a Biomarker in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
- Author
-
Smukowska-Gorynia, Anna, primary, Marcinkowska, Justyna, additional, Chmara, Ewa, additional, Malaczynska-Rajpold, Katarzyna, additional, Slawek-Szmyt, Sylwia, additional, Cieslewicz, Artur, additional, Janus, Magdalena, additional, Araszkiewicz, Aleksander, additional, Jankiewicz, Stanislaw, additional, Komosa, Anna, additional, Olasinska-Wisniewska, Anna, additional, Tomaszewska, Iga, additional, and Mularek-Kubzdela, Tatiana, additional
- Published
- 2018
- Full Text
- View/download PDF
33. The “bouncing” catheter
- Author
-
Malaczynska-Rajpold, Katarzyna, primary, Kurzyna, Marcin, additional, Koteja, Andrzej, additional, Torbicki, Adam, additional, and Mularek-Kubzdela, Tatiana, additional
- Published
- 2016
- Full Text
- View/download PDF
34. Balloon atrial septostomy in pulmonary arterial hypertension: A beneficial effect on the control of rhythm abnormalities
- Author
-
Malaczynska-Rajpold, Katarzyna, primary, Araszkiewicz, Aleksander, additional, and Mularek-Kubzdela, Tatiana, additional
- Published
- 2016
- Full Text
- View/download PDF
35. 219-03: MR conditional vs non-conditional ICD – safety and quality of heart imaging
- Author
-
Malaczynska-Rajpold, Katarzyna, primary, Kociemba, Anna, additional, Seniuk, Wojciech, additional, Janus, Magdalena, additional, Siniawski, Andrzej, additional, Rozmiarek, Szymon, additional, Pyda, Malgorzata, additional, Mitkowski, Przemyslaw, additional, and Blaszyk, Krzysztof, additional
- Published
- 2016
- Full Text
- View/download PDF
36. Unresectable cardiac pseudoneoplasms causing ventricular tachycardia
- Author
-
Malaczynska-Rajpold, Katarzyna, primary, Blaszyk, Krzysztof, additional, Kurzawa, Pawel, additional, Pyda, Malgorzata, additional, Wachowiak-Baszynska, Hanna, additional, Mularek-Kubzdela, Tatiana, additional, and Grajek, Stefan, additional
- Published
- 2014
- Full Text
- View/download PDF
37. Early Diagnosis and Better Rhythm Management to improve outcomes in patients with Atrial Fibrillation: The 8th AFNET/EHRA Consensus Conference
- Author
-
Guiseppe, Boriani, Diederichsen, Søren, Eisert, Christoph, Schnabel, Renate B., Andreassi Marinelli, Elena, Arbelo, Elena, Boveda, Serge, Buckley, Claire, Camm, A. John, Casadei, Barbara, Chua, Winnie, Dagres, Nikolaos, de Melis, Mirko, Desteghe, Lien, Diederichsen, Søren Zöga, Duncker, David, Eckardt, Lars, Engler, Daniel, Fabritz, Larissa, Freedman, Ben, Gillet, Ludovic, Götte, Andreas, Guasch, Eduard, Hastrup Svendsen, Jesper, Hatem, Stéphane, Häusler, Karl Georg, Healey, Jeff S., Heidbüchel, Hein, Hindricks, Gerhard, Hobbs, Richard, Hübner, Thomas, Kotecha, Dipak, Krekler, Michael, Leclercq, Christophe, Lewalter, Thorsten, Lin, Honghuang, Linz, Dominik, Lip, Gregory Y. H, Løchen, Maja-Lisa, Lucassen, Wim, Malaczynska-Rajpold, Katarzyna, Massberg, Steffen, Merino, José L., Meyer, Ralf, Mont, Lluis, Myers, Michael, Neubeck, Lis, Niiranen, Temu, Oeff, Michael, Oldgren, Jonas, Potpara, Tatjana S., Psaroudakis, Georg, Pürerfellner, Helmut, Ravens, Ursula, Rienstra, Michiel, Rivard, Lena, Scherr, Daniel, Schotten, Ulrich, Shah, Dipen, Sinner, Moritz F., Smolnik, Rüdiger, Steinbeck, Gerhard, Steven, Daniel, Svennberg, Emma, Thomas, Dierk, True Hills, Mellanie, van Gelder, Isabelle C., Vardar, Burcu, Vila Pala, Elena, Wakili, Reza, Wegscheider, Karl, Wieloch, Mattias, Willems, Stephan, Witt, Henning, Ziegler, André, Zink, Matthias, and Kirchhof, Paulus
- Subjects
Artificial intelligence ,Technology ,Cost ,Research ,Bleeding ,Quality of care ,Heart failure ,Outcomes ,Atrial fibrillation ,Anticoagulation ,Dementia ,Catheter ablation ,Cognitive function ,Rhythm management ,Atrial cardiomyopathy ,Research priorities - Abstract
AimsDespite marked progress in the management of atrial fibrillation (AF), detecting AF remains difficult and AF-related complications cause unacceptable morbidity and mortality even on optimal current therapy.Methods and resultsThis document summarizes the key outcomes of the 8th AFNET/EHRA Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Eighty-three international experts met in Hamburg for 2 days in October 2021. Results of the interdisciplinary, hybrid discussions in breakout groups and the plenary based on recently published and unpublished observations are summarized in this consensus paper to support improved care for patients with AF by guiding prevention, individualized management, and research strategies. The main outcomes are (i) new evidence supports a simple, scalable, and pragmatic population-based AF screening pathway; (ii) rhythm management is evolving from therapy aimed at improving symptoms to an integrated domain in the prevention of AF-related outcomes, especially in patients with recently diagnosed AF; (iii) improved characterization of atrial cardiomyopathy may help to identify patients in need for therapy; (iv) standardized assessment of cognitive function in patients with AF could lead to improvement in patient outcomes; and (v) artificial intelligence (AI) can support all of the above aims, but requires advanced interdisciplinary knowledge and collaboration as well as a better medico-legal framework.ConclusionsImplementation of new evidence-based approaches to AF screening and rhythm management can improve outcomes in patients with AF. Additional benefits are possible with further efforts to identify and target atrial cardiomyopathy and cognitive impairment, which can be facilitated by AI.
38. Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference
- Author
-
Schnabel, Renate B., Marinelli, Elena Andreassi, Arbelo, Elena, Boriani, Giuseppe, Boveda, Serge, Buckley, Claire M., Camm, A. John, Casadei, Barbara, Chua, Winnie, Dagres, Nikolaos, de Melis, Mirko, Desteghe, Lien, Diederichsen, Soren Zoga, Duncker, David, Eckardt, Lars, Eisert, Christoph, Engler, Daniel, Fabritz, Larissa, Freedman, Ben, Gillet, Ludovic, Goette, Andreas, Guasch, Eduard, Svendsen, Jesper Hastrup, Hatem, Stephane N., Haeusler, Karl Georg, Healey, Jeff S., Heidbuchel, Hein, Hindricks, Gerhard, Hobbs, F. D. Richard, Huebner, Thomas, Kotecha, Dipak, Krekler, Michael, Leclercq, Christophe, Lewalter, Thorsten, Lin, Honghuang, Linz, Dominik, Lip, Gregory Y. H., Lochen, Maja Lisa, Lucassen, Wim, Malaczynska-Rajpold, Katarzyna, Massberg, Steffen, Merino, Jose L., Meyer, Ralf, Mont, Lluis, Myers, Michael C., Neubeck, Lis, Niiranen, Teemu, Oeff, Michael, Oldgren, Jonas, Potpara, Tatjana S., Psaroudakis, George, Purerfellner, Helmut, Ravens, Ursula, Rienstra, Michiel, Rivard, Lena, Scherr, Daniel, Schotten, Ulrich, Shah, Dipen, Sinner, Moritz F., Smolnik, Rudiger, Steinbeck, Gerhard, Steven, Daniel, Svennberg, Emma, Thomas, Dierk, Hills, Mellanie True, van Gelder, Isabelle C., Vardar, Burcu, Pala, Elena, Wakili, Reza, Wegscheider, Karl, Wieloch, Mattias, Willems, Stephan, Witt, Henning, Ziegler, Andre, Zink, Matthias Daniel, Kirchhof, Paulus, Schnabel, Renate B., Marinelli, Elena Andreassi, Arbelo, Elena, Boriani, Giuseppe, Boveda, Serge, Buckley, Claire M., Camm, A. John, Casadei, Barbara, Chua, Winnie, Dagres, Nikolaos, de Melis, Mirko, Desteghe, Lien, Diederichsen, Soren Zoga, Duncker, David, Eckardt, Lars, Eisert, Christoph, Engler, Daniel, Fabritz, Larissa, Freedman, Ben, Gillet, Ludovic, Goette, Andreas, Guasch, Eduard, Svendsen, Jesper Hastrup, Hatem, Stephane N., Haeusler, Karl Georg, Healey, Jeff S., Heidbuchel, Hein, Hindricks, Gerhard, Hobbs, F. D. Richard, Huebner, Thomas, Kotecha, Dipak, Krekler, Michael, Leclercq, Christophe, Lewalter, Thorsten, Lin, Honghuang, Linz, Dominik, Lip, Gregory Y. H., Lochen, Maja Lisa, Lucassen, Wim, Malaczynska-Rajpold, Katarzyna, Massberg, Steffen, Merino, Jose L., Meyer, Ralf, Mont, Lluis, Myers, Michael C., Neubeck, Lis, Niiranen, Teemu, Oeff, Michael, Oldgren, Jonas, Potpara, Tatjana S., Psaroudakis, George, Purerfellner, Helmut, Ravens, Ursula, Rienstra, Michiel, Rivard, Lena, Scherr, Daniel, Schotten, Ulrich, Shah, Dipen, Sinner, Moritz F., Smolnik, Rudiger, Steinbeck, Gerhard, Steven, Daniel, Svennberg, Emma, Thomas, Dierk, Hills, Mellanie True, van Gelder, Isabelle C., Vardar, Burcu, Pala, Elena, Wakili, Reza, Wegscheider, Karl, Wieloch, Mattias, Willems, Stephan, Witt, Henning, Ziegler, Andre, Zink, Matthias Daniel, and Kirchhof, Paulus
- Abstract
Aims Despite marked progress in the management of atrial fibrillation (AF), detecting AF remains difficult and AF-related complications cause unacceptable morbidity and mortality even on optimal current therapy. Methods and results This document summarizes the key outcomes of the 8th AFNET/EHRA Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Eighty-three international experts met in Hamburg for 2 days in October 2021. Results of the interdisciplinary, hybrid discussions in breakout groups and the plenary based on recently published and unpublished observations are summarized in this consensus paper to support improved care for patients with AF by guiding prevention, individualized management, and research strategies. The main outcomes are (i) new evidence supports a simple, scalable, and pragmatic population-based AF screening pathway; (ii) rhythm management is evolving from therapy aimed at improving symptoms to an integrated domain in the prevention of AF-related outcomes, especially in patients with recently diagnosed AF; (iii) improved characterization of atrial cardiomyopathy may help to identify patients in need for therapy; (iv) standardized assessment of cognitive function in patients with AF could lead to improvement in patient outcomes; and (v) artificial intelligence (AI) can support all of the above aims, but requires advanced interdisciplinary knowledge and collaboration as well as a better medico-legal framework. Conclusions Implementation of new evidence-based approaches to AF screening and rhythm management can improve outcomes in patients with AF. Additional benefits are possible with further efforts to identify and target atrial cardiomyopathy and cognitive impairment, which can be facilitated by AI.
39. Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference
- Author
-
Renate B Schnabel, Elena Andreassi Marinelli, Elena Arbelo, Giuseppe Boriani, Serge Boveda, Claire M Buckley, A John Camm, Barbara Casadei, Winnie Chua, Nikolaos Dagres, Mirko de Melis, Lien Desteghe, Søren Zöga Diederichsen, David Duncker, Lars Eckardt, Christoph Eisert, Daniel Engler, Larissa Fabritz, Ben Freedman, Ludovic Gillet, Andreas Goette, Eduard Guasch, Jesper Hastrup Svendsen, Stéphane N Hatem, Karl Georg Haeusler, Jeff S Healey, Hein Heidbuchel, Gerhard Hindricks, F D Richard Hobbs, Thomas Hübner, Dipak Kotecha, Michael Krekler, Christophe Leclercq, Thorsten Lewalter, Honghuang Lin, Dominik Linz, Gregory Y H Lip, Maja Lisa Løchen, Wim Lucassen, Katarzyna Malaczynska-Rajpold, Steffen Massberg, Jose L Merino, Ralf Meyer, Lluıs Mont, Michael C Myers, Lis Neubeck, Teemu Niiranen, Michael Oeff, Jonas Oldgren, Tatjana S Potpara, George Psaroudakis, Helmut Pürerfellner, Ursula Ravens, Michiel Rienstra, Lena Rivard, Daniel Scherr, Ulrich Schotten, Dipen Shah, Moritz F Sinner, Rüdiger Smolnik, Gerhard Steinbeck, Daniel Steven, Emma Svennberg, Dierk Thomas, Mellanie True Hills, Isabelle C van Gelder, Burcu Vardar, Elena Palà, Reza Wakili, Karl Wegscheider, Mattias Wieloch, Stephan Willems, Henning Witt, André Ziegler, Matthias Daniel Zink, Paulus Kirchhof, General practice, ACS - Heart failure & arrhythmias, APH - Personalized Medicine, APH - Quality of Care, Schnabel, Renate B/0000-0001-7170-9509, Rienstra, Michiel/0000-0002-2581-070X, Pala, Elena/0000-0002-1074-990X, Schnabel, Renate B., Marinelli, Elena Andreassi, Arbelo, Elena, Boriani, Giuseppe, Boveda, Serge, Buckley, Claire M., Camm, A. John, Casadei, Barbara, Chua, Winnie, Dagres, Nikolaos, de Melis, Mirko, DESTEGHE, Lien, Diederichsen, Soren Zoga, Duncker, David, Eckardt, Lars, Eisert, Christoph, Engler, Daniel, Fabritz, Larissa, Freedman, Ben, Gillet, Ludovic, Goette, Andreas, Guasch, Eduard, Svendsen, Jesper Hastrup, Hatem, Stephane N., Haeusler, Karl Georg, Healey, Jeff S., HEIDBUCHEL, Hein, Hindricks, Gerhard, Hobbs, F. D. Richard, Huebner, Thomas, Kotecha, Dipak, Krekler, Michael, Leclercq, Christophe, Lewalter, Thorsten, Lin, Honghuang, Linz, Dominik, Lip, Gregory Y. H., Lochen, Maja Lisa, Lucassen, Wim, Malaczynska-Rajpold, Katarzyna, Massberg, Steffen, Merino, Jose L., Meyer , Ralf, Mont, Lluis, Myers, Michael C., Neubeck, Lis, Niiranen, Teemu, Oeff, Michael, Oldgren, Jonas, Potpara, Tatjana S., Psaroudakis, George, Purerfellner, Helmut, Ravens, Ursula, Rienstra, Michiel, Rivard, Lena, Scherr, Daniel, Schotten, Ulrich, Shah , Dipen, Sinner, Moritz F., Smolnik, Rudiger, Steinbeck, Gerhard, Steven, Daniel, Svennberg, Emma, Thomas, Dierk, Hills, Mellanie True, van Gelder, Isabelle C., Vardar, Burcu, Pala, Elena, Wakili, Reza, Wegscheider, Karl, Wieloch, Mattias, Willems , Stephan, Witt, Henning, Ziegler, Andre, Zink, Matthias Daniel, Kirchhof, Paulus, Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9), and RS: Carim - H08 Experimental atrial fibrillation
- Subjects
Artificial intelligence ,Technology ,Consensus ,Cost ,Medizin ,Heart failure ,Outcomes ,Guidelines ,EHRA/HRS/APHRS/SOLAECE EXPERT CONSENSUS ,Anticoagulation ,Cognition ,QUALITY-OF-LIFE ,Physiology (medical) ,MAGNETIC-RESONANCE ,Humans ,PULMONARY VEIN ISOLATION ,CARDIOVASCULAR EVENTS ,Stroke/prevention & control ,AFNET ,Atrial cardiomyopathy ,Atrial fibrillation ,Bleeding ,Catheter ablation ,Cognitive function ,Consensus statement ,Dementia ,EHRA ,Integrated care ,Quality of care ,Research ,Research priorities ,Rhythm management ,Screening ,Stroke ,ORAL ANTICOAGULANTS ,CARDIOMYOPATHIES DEFINITION ,RISK PREDICTION ,Early Diagnosis ,Human medicine ,Cardiology and Cardiovascular Medicine ,FOLLOW-UP ,Atrial Fibrillation/complications - Abstract
Europace : the European journal of pacing, arrhythmias and cardiac electrophysiology euac062 (2022). doi:10.1093/europace/euac062, Published by Oxford Univ. Press, Oxford
- Published
- 2022
- Full Text
- View/download PDF
40. Genetic testing for inherited arrhythmia syndromes and cardiomyopathies: results of the European Heart Rhythm Association survey.
- Author
-
Zeljkovic I, Gauthey A, Manninger M, Malaczynska-Rajpold K, Tfelt-Hansen J, Crotti L, Behr ER, Migliore F, Wilde A, Chun J, and Conte G
- Subjects
- Humans, Europe, Practice Patterns, Physicians' statistics & numerical data, Health Services Accessibility, Guideline Adherence statistics & numerical data, Predictive Value of Tests, Surveys and Questionnaires, Genetic Testing statistics & numerical data, Arrhythmias, Cardiac genetics, Arrhythmias, Cardiac diagnosis, Cardiomyopathies genetics, Cardiomyopathies diagnosis, Health Care Surveys, Genetic Predisposition to Disease
- Abstract
Aims: Indications and clinical impact of genetic testing for cardiac diseases have increased significantly over the past years. The aim of this physician-based European Heart Rhythm Association (EHRA) survey was to assess current clinical practice and access to genetic testing for cardiac diseases across European Society of Cardiology countries and to evaluate adherence to the 2022 EHRA/HRS/APHRS/LAHRS Expert Consensus Statement on genetic testing., Methods and Results: An online questionnaire composed of 28 questions was submitted to the EHRA Research Network and European Reference Network GUARD-Heart healthcare partners and promoted via dedicated social media channels. There were 357 respondents from 69 countries, 40% working in a hospital setting with a cardiac genetic service and/or a dedicated clinic focusing on inherited cardiac diseases and 27% with an onsite genetic laboratory. No genetic testing or low annual rate (<10/year) was declared by 39% of respondents. The majority of respondents (78%) declared issues or limitations to genetic testing access in their clinical practice. The main reasons for not providing or limited access to genetic testing were no availability of dedicated unit or genetic laboratory (35%) or reimbursement issues (25%). The most frequently reported indication for genetic testing was diagnostic purpose (55%). Most respondents (92%) declared offering genetic testing preceded by genetic counselling and 42% regular multidisciplinary evaluations for patients with cardiac genetic diseases. The perceived value of genetic testing in the diagnostic, prognostic, and therapeutic assessment was variable (67, 39, and 29%, respectively) and primarily based on the specific inherited disease. The majority of respondents recommended cascade genetic testing for the first-degree family members in case of pathogenic/likely pathogenic variant in the proband., Conclusion: This survey highlights a significant heterogeneity of genetic testing access and provision and issues attributable to the availability of dedicated unit/genetic laboratory and reimbursement. However, adequate adherence to indications in the current recommendations for genetic testing in patients with cardiac diseases was observed., Competing Interests: Conflict of interest: none declared., (© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.)
- Published
- 2024
- Full Text
- View/download PDF
41. Occupational radiation exposure of electrophysiology staff with reproductive potential and during pregnancy: an EHRA survey.
- Author
-
Adeliño R, Malaczynska-Rajpold K, Perrotta L, Manninger M, Vanduynhoven P, Nesti M, Goanță EV, Waldmann V, Pavlovic N, Farkowski MM, Guerra JM, Penela D, Boveda S, and Chun JKR
- Subjects
- Male, Pregnancy, Female, Humans, Adolescent, Surveys and Questionnaires, Reproduction, Cardiac Electrophysiology, Radiation Dosage, Radiation Injuries, Radiation Exposure adverse effects, Radiation Exposure prevention & control, Occupational Exposure adverse effects, Occupational Exposure prevention & control
- Abstract
Aims: Electrophysiology (EP) is a growing field in cardiology, with an increasing involvement of young people. Nevertheless, concerns about radiation exposure and its impact on reproduction and pregnancy may discourage the choice of an EP career. The study is aimed at investigating the level of awareness and main sources of concern about the effects of radiation on reproductive potential and pregnancy, exploring the safety measures adopted in different EP labs, and verifying the adherence to the current guidelines., Methods and Results: An online survey was conducted using the European Heart Rhythm Association (EHRA) infrastructure from April to June 2022. A total of 252 EP personnel (42% women) participated, from 50 countries and different professional roles. Most participants expressed concerns regarding the effects of radiation on reproductive capacity (67.1%) and offspring diseases (68.2%). Only 37.9% of participants were aware of the EHRA 2017 consensus document about occupational radiation exposure. Most participants (80.9%) considered that occupational radiation during pregnancy is not safe. EP female staff were not allowed to work in the EP lab during pregnancy in 48.1% of cases. Zero-fluoroscopy was the preferred choice to continue working in the EP lab during pregnancy., Conclusion: EP staff, including both men and women, have concerns about the effects of radiation on reproductive capacity. Despite the recommendations issued by international bodies, implementation of the policies regarding pregnancy and occupational radiation exposure is heterogeneous. Zero-fluoroscopy is the preferred approach to ensure safety during pregnancy in the EP lab., Competing Interests: Conflict of interest: The authors declare that there are no conflicts of interest regarding this article., (© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.)
- Published
- 2023
- Full Text
- View/download PDF
42. Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference.
- Author
-
Schnabel RB, Marinelli EA, Arbelo E, Boriani G, Boveda S, Buckley CM, Camm AJ, Casadei B, Chua W, Dagres N, de Melis M, Desteghe L, Diederichsen SZ, Duncker D, Eckardt L, Eisert C, Engler D, Fabritz L, Freedman B, Gillet L, Goette A, Guasch E, Svendsen JH, Hatem SN, Haeusler KG, Healey JS, Heidbuchel H, Hindricks G, Hobbs FDR, Hübner T, Kotecha D, Krekler M, Leclercq C, Lewalter T, Lin H, Linz D, Lip GYH, Løchen ML, Lucassen W, Malaczynska-Rajpold K, Massberg S, Merino JL, Meyer R, Mont L, Myers MC, Neubeck L, Niiranen T, Oeff M, Oldgren J, Potpara TS, Psaroudakis G, Pürerfellner H, Ravens U, Rienstra M, Rivard L, Scherr D, Schotten U, Shah D, Sinner MF, Smolnik R, Steinbeck G, Steven D, Svennberg E, Thomas D, True Hills M, van Gelder IC, Vardar B, Palà E, Wakili R, Wegscheider K, Wieloch M, Willems S, Witt H, Ziegler A, Daniel Zink M, and Kirchhof P
- Subjects
- Humans, Artificial Intelligence, Early Diagnosis, Consensus, Cognition, Atrial Fibrillation complications, Atrial Fibrillation diagnosis, Atrial Fibrillation therapy, Stroke prevention & control
- Abstract
Despite marked progress in the management of atrial fibrillation (AF), detecting AF remains difficult and AF-related complications cause unacceptable morbidity and mortality even on optimal current therapy. This document summarizes the key outcomes of the 8th AFNET/EHRA Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Eighty-three international experts met in Hamburg for 2 days in October 2021. Results of the interdisciplinary, hybrid discussions in breakout groups and the plenary based on recently published and unpublished observations are summarized in this consensus paper to support improved care for patients with AF by guiding prevention, individualized management, and research strategies. The main outcomes are (i) new evidence supports a simple, scalable, and pragmatic population-based AF screening pathway; (ii) rhythm management is evolving from therapy aimed at improving symptoms to an integrated domain in the prevention of AF-related outcomes, especially in patients with recently diagnosed AF; (iii) improved characterization of atrial cardiomyopathy may help to identify patients in need for therapy; (iv) standardized assessment of cognitive function in patients with AF could lead to improvement in patient outcomes; and (v) artificial intelligence (AI) can support all of the above aims, but requires advanced interdisciplinary knowledge and collaboration as well as a better medico-legal framework. Implementation of new evidence-based approaches to AF screening and rhythm management can improve outcomes in patients with AF. Additional benefits are possible with further efforts to identify and target atrial cardiomyopathy and cognitive impairment, which can be facilitated by AI., Competing Interests: Conflict of interest: RBS has received lecture fees and advisory board fees from BMS/Pfizer outside this work and has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme under the grant agreement No 648131, from the European Union's Horizon 2020 research and innovation programme under the grant agreement No 847770 (AFFECT-EU) and German Center for Cardiovascular Research (DZHK e.V.) (8121710103); German Ministry of Research and Education (BMBF 01ZX1408A) and ERACoSysMed3 (031L0239).EAM is employee of Daiichi Sankyo Europe GmbH producing and marketing an oral anticoagulant (edoxaban). EA has received consulting / speaker fees for Biosense Webster. GB has received speaker's fees of small amount from Boston, Bayer, Daiichi, Boehringer. SB is consultant for Medtronic, Boston Scientific, Microport, and Zoll. JC has received consulting fees / honoraria fees from Acesion, Allergan, Alta Thera, Arca, lncarda, Menarini, Milestone, Sanofi, Bayer, Daiichi Sankyo, Pfizer, Abbott, Biosense Webster, Biotronik, Boston Scientific, Lilly, Medtronic, Johnson and Johnson. BC has received in kind contribution for research Support from iRhythm. WC has received advisory board fees for Roche Diagnostics AG. MDM is employee of Medtronic. SZB has received fees as member of Advisory Board in Bristol Myers Squibb-Pfizer. DD has received fees from Abbott, Astra Zenica, Bayer, Bosten Scientific, Bristol Myers Squibb-Pfizer, Medtonic, Zoll. LE has received lecture Honoria from Medtronic, Biotronik, Boston Scientific, Boehringer Ingelheim, Daiichy Sankyo, Bayer, MMS, Pfizer, Sanofi and received research grants from DFG and DGK. CE is employee of Preventicus GmbH. LF has received institutional research grants and non-financial support from European Union, DFG, British Heart Foundation, Medical Research Council (UK), NIHR, and several biomedical companies. The Institute of Cardiovascular Research, University of Birmingham, has received an Accelerator Award by the British Heart Foundation M/18/2/34218. LF is listed as inventor of two patents held by University of Birmingham (Atrial Fibrillation Therapy WO 2015140571, Markers for Atrial Fibrillation WO 2016012783). BF receiving fees from Bristol-Myers Squibb and Pfizer Alliance, Bayer, Daiichi Sankyo, Omron. (largely speaker fees and travel support for speaking at session or official satellites of large international/continental society meetings) and investigator-initiated research grants to the institution from Bristol-Myers and Squibb and Pfizer Alliance and Ownership / Employee of Nil. LG and AZ are employees of Roche Diagnostics International Ltd. AG has received funding from Daiichi Sankyo, Astra Zenica, Bayer, Bristol Myers Squibb-Pfizer, Viola, Medtonic, Berlin Charitè. JHS has received Advisory board fees in Medtronic and Speaker fee from Medtronic. KGH has received fees from Abbott, Alexion, AMARIN, AstraZeneca, Bayer, Biotronik, Boehringer Ingelheim, Bristol-Myers-Squibb, Daiichi Sankyo, Edwards Lifesciences, Medtronic, Pfizer, Premier Research, SUN Pharma and W. L. Gare & Associates and Research Grants from Bayer Vital, Sanofi-Aventis. JSH received fees from Boston Scientific, Servier, Bayer, Myokardia, Bristol-Myers-Squibb, Pfizer, and research grants from Medtronic, Boston Scientific, Bristol-Myers-Squibb, Abbott. HH has received lecture and consultancy fees from Abbott, Biotronik, Bristol-Myers-Squibb- Pfizer, Medscape, Daiichi Sankyo, Springer Healthcare Ltd and receive un conditional research grants through the Univerity of Antwerp and/or University of Hasselt from Abbott, Bayer, Biotronik, Biosense-Webster, Fibrickeck/Qompium, Medtronic, Bristol-Myers-Squibb- Pfizer, Boston Scientific, Daiichi Sankyo and Boehringer Ingelheim. RH has received speacker fees from BI, Bayer and Bristol-Myers-Squibb- Pfizer and AZ. TH is CEO of Preventicus GmbH. DK has received funding from Bayer, AtriCure, Protherics Medicines Development and Myokardia and Research grant from rants from the National Institute for Health Research (NIHR CDF-2015-08-074 RATE-AF; NIHR HTA-130280 DaRe2THINK; NIHR EME- 132974 D2T-NV), the British Heart Foundation (PG/17/55/33087 and AA/18/2/34218), EU/EFPIA IMI (BigData@Heart 116074),the European Society of Cardiology supported by educationalgrants from Boehringer Ingelheim/BMS-Pfizer Alliance/Bayer/Daiichi Sankyo/Boston Scientific, the NIHR/the University of Ox- ford Biomedical Research Centre, and British Heart Foundation/ the University of Birmingham Accelerator Award (STEEER-AF NCT04396418), Amomed Pharma, and IRCCS San Raffaele/Menarini (beta-blockers in Heart Failure Collaborative Group NCT0083244). MK is employee of Bristol-Myers and Squibb. CL has received fees from medtonic, Boston Scientific, Biotronik and Bristol-Myers and Squibb- Pfizer and research grants from Rennes Univerity, Metronik, Biotonik and Boston Scientific. DL has received research grant for EHRA-PATHS, NovoNordisk Young Investigator Award. MLL has received lecture fees from Bristol-Myers and Squibb and research grant from H2020 AFFECT-EU (grant No. 847770). SM has received research grant from Daiichi Sankyo (EPDAURUS IIT) and Bristol-Myers and Squibb (APPROACH ACS AF IIT). JLM has received Abbott, Boston Scientific, Biotronik, Boehringer Ingelheim, Sanofi, Microport and received research grants from Medtronic, Abbott, Microport, Biosense. RM is employee of Medtronic. LM is Stockholder for Galgomedical and Corify and receiving consuting fees from Abbott, Biosense-Webster, Bosten Scientific, Medtronik and receiving research grants from Abbott, Biosense-Webster, Bosten Scientific, Medtronik. LN has received consulting fees from Bristol-Myers and Squibb- Pfizer. GP is employee of Bayer AG. HP has received consulting fees from Abbott, Biosense-Webster, Bosten Scientific, Medtronik and receiving research grants from Abbott, Bayer, Biosense-Webster, Bosten Scientific, Medtronik, Bristol-Myers and Squibb- Pfizer. MR has received consulting fees for Medtonic, Arca BiopharmaInc, Roche and received research grants from Dutch Heart Foundation: RACE V, RED-CVD, CVON-AI, DECISION studies; grant from SJM/Abbott to institution: VIP-HF study; Grant for Medtronic to institution: Cryoballoon AF registry/biobank study. The other authors declare that there is no conflict of interest.LR has received research grants from Canadian Insititute of Health research and Byer Inc. U.S. received consultancy fees or honoraria from Università della Svizzera Italiana (USI, Switzerland), Roche Diagnostics (Switzerland), EP Solutions Inc. (Switzerland), Johnson & Johnson Medical Limited, (United Kingdom), Bayer Healthcare (Germany). U.S. is co-founder and shareholder of YourRhythmics BV, a spin-off company of the University Maastricht and Research grant from the Dutch Heart Foundation (CVON RACE V, CVON2014–09) European Union's Horizon 2020 Research and Innovation Program granted to MS under the Marie Sklodowska-Curie grant agreement #813716 (TRAIN-HEART Innovative Training Network), and various other programs of the European Union granted to US (ITN Network Personalize AF: Personalized Therapies for Atrial Fibrillation: a translational network – grant #860974; CATCH ME: Characterizing Atrial fibrillation by Translating its Causes into Health Modifiers in the Elderly – grant #633196; MAESTRIA: Machine Learning Artificial Intelligence Early Detection Stroke Atrial Fibrillation – grant #965286; REPAIR: Restoring cardiac mechanical function by polymeric artificial muscular tissue – grant #952166). DS has received consultation fees from Biosense Webster, Abbott, Boston Scientific, Consultant with stock option: SentiAR, Arga Medtech. RS is employee of Daiichi Sankyo Europe GmbH. DS has received consultation fees from Boston Scientific, Abbott and Research grant from Biosense Webster. ES has received lecture fees from Bayer, Bristol-Myers and Squibb- Pfizer, Boehringer Ingelheim, Johnson & Johnson, Merck Sharp & Dohme and Sanofi. DT has received lecture fees from Bayer Vital, Bristol-Myers and Squibb- Pfizer, Daiichi Sankyo, Medtonic, Zoll CMS, Sanofi, St. Jude Medical and research grant from Daiichi Sankyo. MTH is employee/owner of American Foundation of women's Health /StopAfib.org and employee/owner of True Hills Inc.. BV is employee of Bayer AG. RW has received consultation fees from Boston Scientific, Biotronic, Pfizer, Daiichi Sankyo, Bayer, Adagio Medical and Research grant from Bristol-Myers and Squibb- Pfizer, Boston Scientific. CW has received consulation fees from Biotronik, Boston Scientific, Novartis and research grant from BMBF, AFNET, DZHK, Biotronik. MW is employee and shareholder of Sanofi. SW has received Consulting fees from Boston Scientific, Abbott, Bayer, Bristol-Myers and Squibb- Pfizer, Boehringer Ingelheim and research grant from Boston Scientific. HW is employee and stockholder of Pfizer Germany. MDZ has received advisory and speaker fee from Bristol-Myers and Squibb- Pfizer. PK reports grants and non-financial support from BMBF (German Ministry of Education and Research), grants from Sanofi and Abbott, grants and non-financial support from EHRA (European Heart Rhythm Association), and grants from German Heart Foundation and DZHK (German Center for Cardiovascular Research), during the conduct of the study, and grants from European Union, British Heart Foundation, Leducq Foundation, Medical Research Council (UK), and non-financial support from German Centre for Heart Research, outside the submitted work; in addition, P.K. has a patent Atrial Fibrillation Therapy WO 2015140571 issued to University of Birmingham and a patent Markers for Atrial Fibrillation WO 2016012783 issued to University of Birmingham., (© The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology.)
- Published
- 2023
- Full Text
- View/download PDF
43. Reimbursement practices for use of digital devices in atrial fibrillation and other arrhythmias: a European Heart Rhythm Association survey.
- Author
-
Boriani G, Svennberg E, Guerra F, Linz D, Casado-Arroyo R, Malaczynska-Rajpold K, Duncker D, Boveda S, Merino JL, and Leclercq C
- Subjects
- Humans, Health Care Surveys, Practice Patterns, Physicians', Treatment Outcome, Surveys and Questionnaires, Atrial Fibrillation diagnosis, Atrial Fibrillation therapy
- Abstract
Since digital devices are increasingly used in cardiology for assessing cardiac rhythm and detecting arrhythmias, especially atrial fibrillation (AF), our aim was to evaluate the expectations and opinions of healthcare professionals in Europe on reimbursement policies for the use of digital devices (including wearables) in AF and other arrhythmias. An anonymous survey was proposed through announcements on the European Heart Rhythm Association website, social media channels, and mail newsletter. Two hundred and seventeen healthcare professionals participated in the survey: 32.7%, reported regular use of digital devices, 45.2% reported that they sometimes use these tools, 18.6% that they do not use but would like to. Only a minority (3.5%) reported a lack of trust in digital devices. The survey highlighted a general propensity to provide medical consultation for suspected AF or other arrhythmias detected by a consumer-initiated use of digital devices, even if time constraints and reimbursement availability emerged as important elements. More than 85% of respondents agreed that reimbursement should be applied for clinical use of digital devices, also in different settings such as post-stroke, post-cardioversion, post-ablation, and in patients with palpitations or syncope. Finally, 73.6% of respondents confirmed a lack of reimbursement fees in their country for physicians' consultations (tracings interpretation) related to digital devices. Digital devices, including wearables, are increasingly and widely used for assessing cardiac rhythm and detecting AF, but a definition of reimbursement policies for physicians' consultations is needed., Competing Interests: Conflict of interest: G.B. received small speaker’s fees from Boston, Boehringer, Daiichi and Bayer, outside of the submitted work. E.S. has received institutional speaker/advisory fees from Bayer, Bristol-Myers Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme. F.G. received small speaker’s fees from Boston, Boehringer-Ingelheim, Bayer, Bristol-Meyer Squibb, Daiichi-Sankyo, outside of the submitted work. J.L.M. received speaker and consultancy fees from Medtronic, Microport, Sanofi, outside of the submitted work. D.D. received speaker fees from Abbott, Astra Zeneca, Bayer, Boston Scientific, Bristol-Myers Squibb, Medtronic, Microport, Pfizer, Zoll. S.B. is consultant for Medtronic, Boston Scientific, Microport, Zoll, and BMS. R.C.-A. received small speaker’s fees from Abbot, Johnson & Johnson, Boston Scientific, outside of the submitted work., (© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2022
- Full Text
- View/download PDF
44. How to use digital devices to detect and manage arrhythmias: an EHRA practical guide.
- Author
-
Svennberg E, Tjong F, Goette A, Akoum N, Di Biase L, Bordachar P, Boriani G, Burri H, Conte G, Deharo JC, Deneke T, Drossart I, Duncker D, Han JK, Heidbuchel H, Jais P, de Oliviera Figueiredo MJ, Linz D, Lip GYH, Malaczynska-Rajpold K, Márquez M, Ploem C, Soejima K, Stiles MK, Wierda E, Vernooy K, Leclercq C, Meyer C, Pisani C, Pak HN, Gupta D, Pürerfellner H, Crijns HJGM, Chavez EA, Willems S, Waldmann V, Dekker L, Wan E, Kavoor P, Turagam MK, and Sinner M
- Subjects
- Humans, Arrhythmias, Cardiac diagnosis, Arrhythmias, Cardiac therapy, Catheter Ablation
- Published
- 2022
- Full Text
- View/download PDF
45. The interpretation of CHA2DS2-VASc score components in clinical practice: a joint survey by the European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, the EHRA Young Electrophysiologists, the Association of Cardiovascular Nursing and Allied Professionals, and the European Society of Cardiology Council on Stroke.
- Author
-
Zhang J, Lenarczyk R, Marin F, Malaczynska-Rajpold K, Kosiuk J, Doehner W, Van Gelder IC, Lee G, Hendriks JM, Lip GYH, and Potpara TS
- Subjects
- Humans, Risk Assessment, Risk Factors, Stroke Volume, Surveys and Questionnaires, Ventricular Function, Left, Atrial Fibrillation, Cardiology, Cardiovascular Nursing, Stroke diagnosis
- Abstract
This European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, EHRA Young Electrophysiologists, Association of Cardiovascular Nursing and Allied Professionals, and European Society of Cardiology (ESC) Council on Stroke joint survey aimed to assess the interpretation of the CHA2DS2-VASc score components and preferred resources for calculating the score. Of 439 respondents, most were general cardiologists (46.7%) or electrophysiologists (EPs) (42.1%). The overall adherence to the ESC-defined scoring criteria was good. Most variation was observed in the interpretation of the significance of left ventricular ejection fraction and brain natriuretic peptide in the scoring for the 'C' component, as well as the 'one-off high reading of blood pressure' to score on the 'H' component. Greater confidence was expressed in scoring the 'H' component (72.3%) compared with the 'C' (46.2%) and 'V' (45.9%) components. Respondents mainly relied on their recall for the scoring of CHA2DS2-VASc score (64.2%). The three most favoured referencing resources varied among different professionals, with pharmacists and physicians relying mainly on memory or web/mobile app, whereas nurses favoured using a web/mobile app followed by memory or guidelines/protocol. In conclusion, this survey revealed overall good adherence to the correct definition of each component in scoring of the 'C', 'H', and 'V' elements of the CHA2DS2-VASc score, although the variation in their interpretations warrants further clarifications. The preferred referencing resources to calculate the score varied among different healthcare professionals. Guideline education to healthcare professionals and updated and unified online/mobile scoring tools are suggested to improve the accuracy in scoring the CHA2DS2-VASc score., (Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.